ArticleO&G open2025
Effect of Social Drivers of Health on Screening for Type 2 Diabetes in Individuals With Gestational Diabetes During Delivery Hospitalization and 4-12 Weeks Postpartum.
Article in O&G open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diabetes Testing Immediately Postpartum After Gestational Diabetes Mellitus: A Randomized Controlled Trial.Obstetrics and gynecology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo prospectively evaluate postpartum diabetes screening rates among individuals with gestational diabetes mellitus (GDM) offered testing during the delivery hospitalization or at 4-12 weeks postpartum compared with historic outpatient-only screening and to assess the role of social and structural drivers of health.
methodsThis retrospective study compared patients with GDM who delivered between January 1 and December 31, 2023 (retrospective cohort), and underwent outpatient screening at 4-12 weeks postpartum with a 75-g 2-hour oral glucose tolerance test (OGTT) with a prospective cohort (June 24-November 5, 2024) of the first 100 patients who underwent screening in the immediate postpartum delivery hospitalization or at 4-12 weeks postpartum. Demographic, social, and structural drivers of health were collected. A sample size of 95 in the prospective group provided 80% power to detect a 50% increase in screening from 32% to 48% (α=0.05).
resultsA greater number of individuals in the prospective cohort completed the OGTT (77.3%, 75/97) compared with the retrospective cohort (31.7%, 98/309,
conclusionThe updated guidance from the American College of Obstetricians and Gynecologists to offer an OGTT during delivery hospitalization in addition to the traditional outpatient approach may increase completion rates across the entire postpartum population regardless of sociodemographic, social, or structural drivers of health. Rather than targeting specific groups, this approach addresses universal barriers to postpartum screening, enhancing overall adherence to postpartum diabetes screening recommendations.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.